Showing 21 - 22 of 22 Results
Development of Clinical Outcome Assessments as New FDA-Qualified Drug Development Tools to Accelerate Therapeutics Development for Opioid and Stimulant Use Disorders (UG3/UH3 Clinical Trial Optional)
FOA Number
Release Date
Expiration Date
Expiration Date
Activity Code(s)
Organizations
Archived
No
Diversity Centers for Genome Research (UG3/UH3 Clinical Trials Optional)
FOA Number
Release Date
Expiration Date
Expiration Date
Activity Code(s)
Clinical Trials
Categories
Archived
No